Results 121 to 130 of about 5,803 (182)

Short-Term Clinical and Immunologic Outcomes Conditional on SVR12 in Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Treated With Direct-Acting Antivirals: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Boonpheng B, Ungprasert P.
europepmc   +1 more source

Consideration of ledipasvir/sofosbuvir as an alternative to glecaprevir/pibrentasvir based upon on-treatment FIB-4 changes and sustained virologic response at 12 weeks in hepatitis C genotype 1 and 2 infections: A propensity score-matched study. [PDF]

Medicine (Baltimore)
Park HJ, Wang H, Jeong J, Seo KI, Shin JW, Park NH.   +5 more
europepmc   +1 more source

Sensitive RP-HPLC method with fluorimetric detection for concurrent quantification of emtricitabine, Daclatasvir and Ledipasvir in human urine. [PDF]

Sci Rep
Youssef AA, Magdy N, Hussein LA, El-Kosasy AM.   +3 more
europepmc   +1 more source

Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting. [PDF]

Eur J Clin Microbiol Infect Dis
Pokorska-Śpiewak M, Dobrzeniecka A, Talarek E, Aniszewska M, Marczyńska M.   +4 more
europepmc   +1 more source

Real-world treatment of pediatric Hepatitis C: A Florida experience. [PDF]

J Pediatr Gastroenterol Nutr
Adawi M, Gonzalez-Peralta RP, McGoogan K.   +2 more
europepmc   +1 more source

An eco-friendly chemometrics assisted UV spectrophotometric method for simultaneous determination of sofosbuvir, simeprevir and ledipasvir in pharmaceuticals. [PDF]

BMC Chem
Alshehri A, Alqahtani A, Alsayari A, Almrasy AA.   +3 more
europepmc   +1 more source

Exploring stationary phase morphologies as pathways to greener and faster LC for analyzing sofosbuvir and ledipasvir. [PDF]

Sci Rep
Ibrahim AE, Alamir SG, Salman BI, El Deeb S, Al-Harrasi A.   +4 more
europepmc   +1 more source

Health Disparities in Achieving Sustained Virologic Response Among Patients With Chronic Hepatitis C: A Retrospective Single-Center Study. [PDF]

Cureus
Leach E, Rana R, Nguyen C, Reinecke J, Hall A, Velagapudi M.   +5 more
europepmc   +1 more source

Hepatitis C in the Direct-Acting Antiviral Era: Immunopathogenesis, Dendritic Cells and Modern Clinical Management. [PDF]

Biomedicines
Kurmangaliyeva K, Kosherova B, Mukatova I, Baibusunova A, Yeshmagambetova Z, Askarova K, Kazangapova A, Shlymova R.   +7 more
europepmc   +1 more source

Generic <i>vs</i> brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children. [PDF]

World J Hepatol
Mogahed E, Ghita H, Enayet A, Yasin N, El-Karaksy H.   +4 more
europepmc   +1 more source